StephenE.FollansbeeMD

PubMed

• 379 citations
  No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting
  Jonathan E. Volk, Julia L. Marcus, Tony Phengrasamy, Derek R. Blechinger, Dong Phuong Nguyen, Stephen Follansbee, C. Bradley Hare> ;Clinical Infectious Diseases. 2015 Nov 15
• 198 citations
  Early Experiences Implementing Pre-exposure Prophylaxis (PrEP) for HIV Prevention in San Francisco
  Albert Y. Liu, Stephanie E. Cohen, Stephen Follansbee, Deborah Cohan, Shannon Weber, Darpun Sachdev, Susan Buchbinder> ;Plos Medicine. 2014 Mar 4
• 48 citations
  Risk Factors for Anal HPV Infection and Anal Precancer in HIV-Infected Men Who Have Sex With Men
  Lauren Schwartz, Philip E. Castle, Stephen Follansbee, Sylvia Borgonovo, Barbara Fetterman, Diane Tokugawa, Thomas Lorey, Vikrant V. Sahasrabuddhe, Patricia Luhn, Juli...> ;The Journal of Infectious Diseases. 2013 Dec 1
• 49 citations
  Human Papillomavirus Genotype Attribution and Estimation of Preventable Fraction of Anal Intraepithelial Neoplasia Cases Among HIV-Infected Men Who Have Sex With Men
  Vikrant V. Sahasrabuddhe, Philip E. Castle, Stephen Follansbee, Sylvia Borgonovo, Diane Tokugawa, Lauren Schwartz, Thomas Lorey, Brandon LaMere, Julia C. Gage, Barbara...> ;The Journal of Infectious Diseases. 2013 Feb 1
• 43 citations
  Interrater agreement of anal cytology.
  Teresa M. Darragh, Diane Tokugawa, Philip E. Castle, Stephen Follansbee, Sylvia Borgonovo, Brandon LaMere, Lauren Schwartz, Julia C. Gage, Barbara Fetterman, Thomas Lo...> ;Cancer Cytopathology. 2013 Feb 1
• 20 citations
  A Comparison of Human Papillomavirus Genotype-Specific DNA and E6/E7 mRNA Detection to Identify Anal Precancer among HIV-Infected Men Who Have Sex with Men
  Philip E. Castle, Stephen Follansbee, Sylvia Borgonovo, Diane Tokugawa, Lauren Schwartz, Thomas Lorey, Brandon LaMere, Julia C. Gage, Barbara Fetterman, Teresa M. Darr...> ;Cancer Epidemiology, Biomarkers & Prevention. 2013 Jan 1
• 60 citations
  Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM
  Nicolas Wentzensen, Stephen Follansbee, Sylvia Borgonovo, Diane Tokugawa, Lauren Schwartz, Thomas Lorey, Vikrant V. Sahasrabuddhe, Brandon LaMere, Julia C. Gage, Barba...> ;AIDS. 2012 Nov 13
• 45 citations
  Low rates of hepatitis screening and vaccination of HIV-infected MSM in HIV clinics.
  Karen W. Hoover, Mary Butler, Kimberly A. Workowski, Stephen Follansbee, Beau Gratzer, C. Bradley Hare, Barbara Johnston, John L. Theodore, Guoyu Tao, Bryce D. Smith, ...> ;Sexually Transmitted Diseases. 2012 May 1
• 22 citations
  The efficacy of an anti-CD4 monoclonal antibody for HIV-1 treatment
  W. Jeffrey Fessel, Brooke Anderson, Stephen Follansbee, Mark A. Winters, Stanley Lewis, Steven Weinheimer, Christos J. Petropoulos, Robert W. Shafer> ;Antiviral Research. 2011 Dec 1
• 21 citations
  A comparison of dacron versus Flocked nylon swabs for anal cytology specimen collection.
  Julia C. Gage, Sylvia Borgonovo, Stephen Follansbee, Nicolas Wentzensen, Patti E. Gravitt, Niels Grabe, Bernd Lahrmann, Philip E. Castle> ;Acta Cytologica. 2011 Jul 22
• 88 citations
  STD screening of HIV-infected MSM in HIV clinics.
  Karen W. Hoover, Mary Butler, Kimberly A. Workowski, Felix Carpio, Stephen Follansbee, Beau Gratzer, Brad Hare, Barbara Johnston, John L. Theodore, Michael Wohlfeiler,...> ;Sexually Transmitted Diseases. 2010 Dec 1
• 4 citations
  Increased rates of appendicitis in HIV-infected men: 1991-2005.
  Daniel B. Klein, Leo B. Hurley, Michael A. Horberg, Michael J. Silverberg, Stephen Follansbee, Jason Flamm, Gary M. Green> ;Journal of Acquired Immune Deficiency Syndromes. 2009 Sep 1
• 25 citations
  Virologic outcomes of changing enfuvirtide to raltegravir in HIV-1 patients well controlled on an enfuvirtide based regimen: 24-week results of the CHEER study.
  William J. Towner, Daniel J. Klein, Hai Linh Kerrigan, Stephen Follansbee, Kalvin Yu, Michael A. Horberg> ;Journal of Acquired Immune Deficiency Syndromes. 2009 Aug 1
• The state of the science of HIV treatment approaches.
  Follansbee, S. E.> ;Focus (San Francisco, Calif.). 2007 May 29
• 89 citations
  Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy
  Michael A. Horberg, Leo B. Hurley, Daniel B. Klein, Stephen Follansbee, Charles P. Quesenberry, Jason Flamm, Gary M. Green, Tye Luu> ;Archives of Surgery. 2006 Dec 1
• 79 citations
  HIV-1 Protease and Reverse-Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance
  Soo-Yon Rhee, W. Jeffrey Fessel, Andrew R. Zolopa, Leo B. Hurley, Tommy F. Liu, Jonathan Taylor, Dong Phuong Nguyen, Sally Slome, Daniel B. Klein, Michael A. Horberg, ...> ;The Journal of Infectious Diseases. 2005 Aug 1
• 102 citations
  Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy
  Rami Kantor, Robert W. Shafer, Stephen Follansbee, Jonathan Taylor, David Shilane, Leo B. Hurley, Dong-Phuong Nguyen, David Katzenstein, W. Jeffrey Fessel> ;AIDS. 2004 Jul 23
• 23 citations
  High-density lipoprotein cholesterol is low in HIV-infected patients with lipodystrophic fat expansions: implications for pathogenesis of fat redistribution.
  W. Jeffrey Fessel, Stephen Follansbee, John Rego> ;AIDS. 2002 Sep 6
• 14 citations
  Abacavir expanded access program for adult patients infected with human immunodeficiency virus type 1.
  Harold A. Kessler, Judy Johnson, Stephen E. Follansbee, Michael Sension, Donna Mildvan, Gladys E. Sepulveda, Nicholaos C. Bellos, Seth Hetherington> ;Clinical Infectious Diseases. 2002 Feb 15
• 20 citations
  Tolerance and Pharmacokinetic Interactions of Rifabutin and Azithromycin
  Richard Hafner, James Bethel, Harold C. Standiford, Stephen Follansbee, David L. Cohn, Ron E. Polk, Larry A. Mole, Ralph H. Raasch, Princy Kumar, David M. Mushatt, Geo...> ;Antimicrobial Agents and Chemotherapy. 2001 May 1
• 3 citations
  Does use of potent antiretroviral therapy differ by health care setting
  Jeffrey Fessel, Stephen Follansbee, Leo B. Hurley, Daniel B. Klein> ;JAMA. 1999 May 12
• 64 citations
  Tolerance and Pharmacokinetic Interactions of Rifabutin and Clarithromycin in Human Immunodeficiency Virus-Infected Volunteers
  Richard Hafner, James Bethel, Maureen Power, Bernard Landry, Mary Banach, Larry A. Mole, Harold C. Standiford, Stephen Follansbee, Princy Kumar, Ralph H. Raasch, David...> ;Antimicrobial Agents and Chemotherapy. 1998 Mar 1
• 126 citations
  Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease
  Sunwen Chou, Gail I. Marousek, Susan Guentzel, Stephen E. Follansbee, Margaret E. Poscher, Jacob Lalezari, R C Miner, W. Lawrence Drew> ;The Journal of Infectious Diseases. 1997 Sep 1
• 17 citations
  Diagnosis of Cytomegalovirus (CMV) Polyradiculopathy and Documentation of In Vivo Anti-CMV Activity in Cerebrospinal Fluid by Using Branched DNA Signal Amplification a...
  Jennifer Flood, W L Drew, R C Miner, Dragana Jekic-McMullen, Lu-Ping Shen, Janice A. Kolberg, Janice Garve, Stephen E. Follansbee, Margaret E. Poscher> ;The Journal of Infectious Diseases. 1997 Aug 1
• 211 citations
  Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group
  Stephen A. Spector, George McKinley, Jacob Lalezari, Tobias Samo, Robert Andruczk, Stephen E. Follansbee, Paula D. Sparti, Diane V. Havlir, Gail Simpson, William Buhle...> ;The New England Journal of Medicine. 1996 Jun 6
• Join now to see all